- Phase I study of DQ-2556, a new parenteral 3-quaternary ammonium cephalosporin antibiotic. Nakashima, M., Uematsu, T., Kanamaru, M., Mizuno, A., Matsubayashi, K., Okazaki, O., Hashimoto, S., Hakusui, H., Osada, Y. Journal of clinical pharmacology. (1993)